Clinical Trial Update: Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia [NA]

View source ↗

Summary

This clinical trial update reports on how durable the complete molecular remission is after stopping imatinib in patients with chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Myeloid Leukemia, Chronic | NA | Status: COMPLETED